Amarin Corp PLC (NAS:AMRN)
$ 0.704 -0.0208 (-2.93%) Market Cap: 289.25 Mil Enterprise Value: -10.54 Mil PE Ratio: 0 PB Ratio: 0.53 GF Score: 42/100

Amarin Corporation plc - Special Call Transcript

Nov 18, 2020 / 09:30PM GMT
Release Date Price: $4.35 (-4.19%)
Operator

Welcome to Amarin Corporation's American Heart Association Scientific Sessions wrap-up event where select scientific publications presented over the weekend will be discussed. This conference call is being recorded today, November 18, 2020.

I will now turn the conference call over to Alina Kolomeyer, Director of Communications at Amarin.

Alina Kolomeyer

Welcome to today's discussion with several distinguished invited guests to explore with our investment community the several important new data sets and analyses related to VASCEPA and REDUCE-IT, presented to the medical community at the American Heart Association Virtual Scientific Sessions 2020.

Please be aware that this conference call will contain forward-looking statements that are intended to be covered under the safe harbor provided by the Private Securities Litigation Reform Act. Examples of such statements include, but are not limited to, our current expectations regarding VASCEPA clinical data and expectation regarding the application of these data to clinical use, in reimbursement and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot